1 | Health | 1.75% | |
2 | Study | 1.32% | |
3 | Cancer | 1.32% | |
4 | Disease | 1.1% | |
5 | New | 0.95% | |
6 | Risk | 0.88% | |
7 | AI | 0.88% | |
8 | Research | 0.73% | |
9 | Heart | 0.66% | |
10 | RSV | 0.51% | |
11 | Therapy | 0.51% | |
12 | Breakthrough | 0.51% | |
13 | Boost | 0.51% | |
14 | Linked | 0.51% | |
15 | Boosts | 0.44% | |
16 | Treatment | 0.44% | |
17 | Brain | 0.44% | |
18 | May | 0.44% | |
19 | Tied | 0.37% | |
20 | Care | 0.37% | |
21 | Higher | 0.37% | |
22 | Eating | 0.37% | |
23 | Can | 0.37% | |
24 | Rates | 0.37% | |
25 | Diabetes | 0.37% | |
26 | Genetic | 0.37% | |
27 | Australia | 0.37% | |
28 | HPV | 0.37% | |
29 | UK | 0.37% | |
30 | Lung | 0.37% | |
31 | Call | 0.29% | |
32 | Type | 0.29% | |
33 | Tool | 0.29% | |
34 | Women | 0.29% | |
35 | Cuts | 0.29% | |
36 | Free | 0.29% | |
37 | Medicine | 0.29% | |
38 | Global | 0.29% | |
39 | Drug | 0.29% | |
40 | Western | 0.29% | |
41 | Finds | 0.29% | |
42 | Ozempic | 0.29% | |
43 | Weight | 0.29% | |
44 | Alzheimers | 0.29% | |
45 | Australians | 0.29% | |
46 | Immunotherapy | 0.29% | |
47 | Aging | 0.29% | |
48 | HIV | 0.29% | |
49 | Sydney | 0.22% | |
50 | Loss | 0.22% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC
MedPage Today
2025-06-04 01:40:15